Free tool
FAERS Monitor: Flonase Allergy Relief
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205434 or its brand name (Flonase Allergy Relief, Fluticasone Propionate). Reports on generic versions are filed under their own applications.
Reports
93,660
Serious
45,178
48% of reports
Hospitalization
20,743
Death reported
4,248
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective7,936
- headache6,387
- fatigue6,263
- dyspnoea6,232
- nausea5,479
- pain4,829
- diarrhoea4,712
- cough4,434
- off label use4,337
- dizziness4,161
- pneumonia3,468
- asthma3,231
- arthralgia3,107
- vomiting3,054
- malaise2,946
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,454 |
| 2005 | 1,543 |
| 2006 | 1,479 |
| 2007 | 1,222 |
| 2008 | 1,131 |
| 2009 | 1,191 |
| 2010 | 1,658 |
| 2011 | 2,027 |
| 2012 | 2,500 |
| 2013 | 1,854 |
| 2014 | 2,311 |
| 2015 | 5,773 |
| 2016 | 7,773 |
| 2017 | 5,677 |
| 2018 | 5,868 |
| 2019 | 5,960 |
| 2020 | 6,402 |
| 2021 | 5,514 |
| 2022 | 5,753 |
| 2023 | 6,080 |
| 2024 | 7,320 |
| 2025 | 7,393 |
| 2026 | 5,773 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,960,499 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| asthmaSignal | 3,231 | 6.6 | 6.4 | 14,926 |
| coughSignal | 4,434 | 3.6 | 3.5 | 8,268 |
| dyspnoeaSignal | 6,232 | 2.5 | 2.4 | 5,638 |
| pneumoniaSignal | 3,468 | 2.4 | 2.3 | 2,904 |
| headacheSignal | 6,387 | 2.3 | 2.2 | 4,792 |
| dizziness | 4,161 | 1.9 | 1.8 | 1,742 |
| fatigue | 6,263 | 1.8 | 1.8 | 2,351 |
| pain | 4,829 | 1.8 | 1.7 | 1,657 |
| arthralgia | 3,107 | 1.7 | 1.6 | 872 |
| diarrhoea | 4,712 | 1.6 | 1.6 | 1,217 |
| nausea | 5,479 | 1.6 | 1.5 | 1,131 |
| malaise | 2,946 | 1.5 | 1.5 | 517 |
| vomiting | 3,054 | 1.5 | 1.4 | 452 |
| drug ineffective | 7,936 | 1.4 | 1.3 | 780 |
| off label use | 4,337 | 1.1 | 1.1 | 51 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.